Abstract:Under conditions of hypoxia, most eukaryotic cells can shift their primary metabolic strategy from predominantly mitochondrial respiration towards increased glycolysis to maintain ATP levels. This hypoxia‐induced reprogramming of metabolism is key to satisfying cellular energetic requirements during acute hypoxic stress. At a transcriptional level, this metabolic switch can be regulated by several pathways including the hypoxia inducible factor‐1α (HIF‐1α) which induces an increased expression of glycolytic enzymes. While this increase in glycolytic flux is beneficial for maintaining bioenergetic homeostasis during hypoxia, the pathways mediating this increase can also be exploited by cancer cells to promote tumor survival and growth, an area which has been extensively studied. It has recently become appreciated that increased glycolytic metabolism in hypoxia may also have profound effects on cellular physiology in hypoxic immune and endothelial cells. Therefore, understanding the mechanisms central to mediating this reprogramming are of importance from both physiologic and pathophysiologic standpoints. In this review, we highlight the role of HIF‐1α in the regulation of hypoxic glycolysis and its implications for physiological processes such as angiogenesis and immune cell effector function. figure legend Schematic outlining the functional physiological consequences of enhanced glycolytic metabolism in endothelial cells and immune cells. This article is protected by copyright. All rights reserved

Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target

Therapeutic Targeting Hypoxia-Inducible Factor (HIF-1) in Cancer: Cutting Gordian Knot of Cancer Cell Metabolism

Hypoxia and Cancer Cell Metabolism

Central role of hypoxia-inducible factor-1α in metabolic reprogramming of cancer cells: A review

Metabolomic Investigations into Hypoxia-Mediated Metabolic Reprogramming of Pancreatic Cancer Cells

Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance

HIF-1α pathway: role, regulation and intervention for cancer therapy

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes

Autonomous Glucose Metabolic Reprogramming of Tumour Cells under Hypoxia: Opportunities for Targeted Therapy

Hypoxia and Metabolism in Metastasis

HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance

Cancer Therapy by Targeting Hypoxia-Inducible Factor-1.

Hypoxia: Intriguing Feature in Cancer Cell Biology

Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation

HIF-1-Regulated Glucose Metabolism: A Key to Apoptosis Resistance?

Therapeutic Targeting of Hypoxia-Inducible Factors in Cancer

HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells

Improving Cancer Immunotherapy: Exploring and Targeting Metabolism in Hypoxia Microenvironment

Regulation of glycolysis by the hypoxia‐inducible factor (HIF): implications for cellular physiology

Targeting Hypoxia-Inducible Factor-1-Mediated Metastasis for Cancer Therapy